FDA approved rucaparib for maintenance treatment of recurrent ovarian, fallopian tube, or primary peritoneal cancer

/0 Comments/in , /by

 

  • FDA approved rucaparib for maintenance treatment of recurrent ovarian, fallopian tube, or primary peritoneal cancer. More Information.
You might also like
FDA approved biosimilar pegfilgrastim to decrease the chance of febrile neutropenia in patients with non-myeloid cancers on myelosuppressive chemotherapy
Pembrolizumab FDA approved for adjuvant treatment of melanoma
Keytruda® FDA approved for recurrent and metastatic Merkel cell carcinoma
Dasatinib FDA approved in paediatric patients with chronic phase Ph+ CML
FDA approved pembrolizumab for 3rd-line PMBCL in adult and pediatric patients
FDA safety alert: use of immunotherapy in metastatic urothelial cancer with low PD-L1 expression
Glasdegib plus low-dose cytarabine (LDAC) approved in elderly AML patients
Obinutuzumab plus chemotherapy FDA approved for follicular lymphoma
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

I-O in Special Populations: Diabetes and Concomitant SteroidsEverolimus suspension approved in TSC-associated partial-onset seizures